Login
$MNOV
$1.41 +$0.01 (0.71%) Close

Company Executives

Officer Age In this role Joined 2025 pay Source
Yuichi Iwaki, M.D., Ph.D. Also a director
President, Chief Executive Officer and Executive Chairman of our Board
76 Not stated 2000 $1,736,711
Jason Kruger
Chief Financial Officer
49 Since 2022
4 years
Not stated Not reported
Kazuko Matsuda, M.D., Ph.D., MPH Also a director
Senior Vice President, Chief Medical Officer
60 Not stated Not stated $1,331,079
David H. Crean
Chief Business Officer
61 Since 2021
5 years
Not stated $120,000

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
5
serving now
Independent
3 of 5
stated in the proxy
Average tenure
11.0 years
from year joined
CEO also chairs the board
Not stated
no chair stated
Director Age On board Independent Committees Other public boards 2025 pay Source
Yuichi Iwaki, M.D., Ph.D.
76 2000
26 years
Not independent None stated None stated Paid as CEO
Kazuko Matsuda, M.D., Ph.D., MPH
60 Not stated Not independent None stated None stated Not stated
Hideki Nagao
69 2017
9 years
Independent None stated None stated $86,313
Nicole Lemerond
50 2023
3 years
Independent None stated InMed Pharmaceuticals, Inc., GeoVax, Inc. $86,313
Carolyn Beaver
68 2020
6 years
Independent None stated MaxLinear, Inc. $86,313

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 29, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support